Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Update

26 Nov 2020 07:00

RNS Number : 5369G
Norman Broadbent PLC
26 November 2020
 

Norman Broadbent plc

("Norman Broadbent", the "Company" or the "Group")

Funding Update

Norman Broadbent (AIM: NBB) - a leading London listed Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services - announces that, in order to strengthen the balance sheet and aid liquidity, the Company has secured a £250,000 six-year term loan facility under the British Business Bank's Coronavirus Business Interruption Loans Scheme (CBILS) from its bankers, Metro Bank PLC (the "Facility").

The Facility can be drawn down at any point before 16th January 2021 with a 12-month interest-free period following drawdown and an interest rate of 4.75% over Metro Bank Base Rate per annum on the drawn down amount thereafter. The funds are repayable commencing 12 months after drawdown in equal monthly instalments for the remaining five years. There will be no penalty for making early repayment(s) of all or part of the Facility.

Additionally, the Company has agreed a new invoice financing facility with Metro Bank PLC and a further £1,500,000 is now available under this facility in addition to the CBILS loan. As of 31 October 2020, the Company had drawn down approximately £332,000 on its existing invoice financing debt facility which will be replaced by the Metro Bank facility in February 2021.

Mike Brennan, Norman Broadbent plc CEO, said:

"We are pleased with these new funding arrangements which are testament to much hard work by our team over recent years. The new invoice discounting facility will greatly improve liquidity and help fuel further growth. In addition, with - it is said - only 1 in 10 applicants in our sector being approved for CBILS, our securing of this loan says much about the increasing strength of our business and how we are regarded.

These new funding arrangements are particularly important as we seek growth opportunities by way of M&A activity, strategic 'tuck-ins' with smaller businesses or teams, and organic growth."

Enquires:

Norman Broadbent plc

Mike Brennan

Steve Smith

 

020 7484 0000

 

WH Ireland Limited

Adrian Hadden

Jessica Cave

Darshan Patel

Matthew Chan

020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLDLFLEFII
Date   Source Headline
22nd Jul 201912:46 pmRNSResult of AGM
22nd Jul 20197:00 amRNSAGM Statement - Norman Broadbent returns to profit
28th Jun 20197:00 amRNSFinal Results and Annual Accounts
10th Jun 201910:32 amRNSCEO recognised by CEO Today magazine
27th Mar 20193:29 pmRNSHolding(s) in Company
13th Feb 20197:00 amRNSTrading Update
28th Sep 20187:00 amRNSInterim Results
6th Jun 201811:49 amRNSResult of AGM
25th May 20187:00 amRNSGrant of Options to Director
14th May 20187:00 amRNSFinal Results and Annual Accounts
30th Apr 20187:00 amRNSChange of Registered Office
22nd Mar 20187:00 amRNSOffice relocation
7th Feb 201810:58 amRNSDirector/PDMR Shareholding
17th Oct 201711:18 amRNSResult of General Meeting
5th Oct 20177:00 amRNSAppointment of new CFO & COO
29th Sep 201712:15 pmRNSResult of ABB
29th Sep 20177:01 amRNSAnnouncement of ABB
29th Sep 20177:00 amRNSHalf-year Report
22nd Aug 201710:36 amRNSCorporate Update & Change of Adviser
6th Jul 20173:36 pmPRNDirector/PDMR Shareholding
4th Jul 20173:36 pmRNSContract win with FTSE 100 corporate
28th Jun 201711:40 amPRNResult of AGM
2nd Jun 201711:12 amPRNDirector Dealing
2nd Jun 20177:58 amPRNFinal Results and Annual Accounts
13th Feb 20177:00 amRNSSenior Management Appointment
30th Dec 201610:36 amPRNDivestment of stake in Social Media Search
28th Nov 20164:37 pmPRNHolding(s) in Company
30th Sep 20165:00 pmPRNTotal Voting Rights
30th Sep 20167:00 amPRNHalf-year Report
23rd Sep 20167:00 amPRNHolding(s) in Company
21st Sep 20162:47 pmPRNHolding(s) in Company
21st Sep 20169:52 amPRNHolding(s) in Company
20th Sep 201611:53 amPRNHolding(s) in Company
19th Sep 201611:10 amPRNResult of general meeting and board changes
1st Sep 20161:16 pmPRNResults of subscription
31st Aug 201610:37 amPRNProposed subscription to raise approximately £2.3m
29th Jun 201612:04 pmPRNResult of AGM
17th Jun 20163:55 pmPRNDirector's Shareholding
16th Jun 20164:13 pmPRNDirector's Shareholding
6th Jun 20167:00 amPRNGrant of Options to Directors
3rd Jun 20167:00 amPRNFinal Results and Annual Accounts
25th Apr 20167:00 amPRNGroup CEO Appointment
11th Mar 20167:00 amPRNChange of Adviser
11th Mar 20167:00 amPRNChange of Adviser
10th Mar 20164:48 pmPRNAIM Disclosure Update
29th Oct 20157:00 amPRNIssue of secured loan notes
30th Sep 20157:00 amPRNHalf-yearly Report
26th Aug 201510:50 amPRNHolding(s) in Company
21st Aug 201510:19 amPRNHolding(s) in Company
9th Jul 201512:58 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.